CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ANIXAnixa Biosciences Inc

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $2.93 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$99.69M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-30 · Catelani Michael (President, COO, & CFO) · BUY
  • 2026-09-28 · Baskies Arnold M (Director) · BUY
  • 2026-09-28 · KUMAR AMIT (Chief Executive Officer) · BUY
  • 2026-09-25 · Titterton Lewis H jr (Director) · BUY
  • 2026-09-14 · KUMAR AMIT (Chief Executive Officer) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders71
Shares held7,059,742
Value$19.85M
Percent of shares outstanding20.75%
As of quarter end2026-06-30
RECENT NEWS
  • Anixa Biosciences reports stable disease for three months in ovarian cancer CAR-T trial
  • Anixa Biosciences treats second patient in fifth cohort of ovarian cancer CAR-T trial
  • Anixa Biosciences granted Australian patent for breast cancer vaccine through 2040
  • Anixa Biosciences appoints Dr. Carmen Guerra to Cancer Business Advisory Board
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Anixa Biosciences Inc (ANIX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit